Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| KCNQ2 Potassium Channel | 21 | 2025 | 42 | 3.780 |
Why?
|
| KCNQ3 Potassium Channel | 11 | 2019 | 19 | 2.170 |
Why?
|
| Axons | 9 | 2015 | 397 | 1.480 |
Why?
|
| Epilepsy | 6 | 2025 | 897 | 1.360 |
Why?
|
| Ankyrins | 7 | 2015 | 96 | 0.990 |
Why?
|
| Dog Diseases | 2 | 2022 | 58 | 0.870 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 65 | 0.760 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2022 | 14 | 0.760 |
Why?
|
| Brain Diseases | 5 | 2025 | 310 | 0.690 |
Why?
|
| Shock | 1 | 2021 | 99 | 0.650 |
Why?
|
| Anaphylaxis | 1 | 2021 | 87 | 0.640 |
Why?
|
| Casein Kinase II | 2 | 2015 | 15 | 0.580 |
Why?
|
| Action Potentials | 4 | 2015 | 521 | 0.580 |
Why?
|
| Neural Conduction | 2 | 2014 | 89 | 0.530 |
Why?
|
| Ranvier's Nodes | 4 | 2014 | 74 | 0.510 |
Why?
|
| Neocortex | 2 | 2014 | 76 | 0.500 |
Why?
|
| Spasms, Infantile | 4 | 2019 | 175 | 0.500 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2015 | 8 | 0.480 |
Why?
|
| KCNQ Potassium Channels | 3 | 2009 | 12 | 0.430 |
Why?
|
| Gain of Function Mutation | 4 | 2023 | 116 | 0.430 |
Why?
|
| Phenylenediamines | 2 | 2025 | 30 | 0.420 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2013 | 27 | 0.410 |
Why?
|
| Health Services for the Aged | 1 | 2013 | 40 | 0.410 |
Why?
|
| Ion Channels | 2 | 2015 | 209 | 0.370 |
Why?
|
| Epilepsy, Benign Neonatal | 2 | 2019 | 13 | 0.370 |
Why?
|
| Neurons | 6 | 2022 | 2050 | 0.350 |
Why?
|
| Sodium Channels | 2 | 2014 | 109 | 0.340 |
Why?
|
| Vertebrates | 1 | 2010 | 39 | 0.340 |
Why?
|
| Seizures | 4 | 2023 | 889 | 0.310 |
Why?
|
| Chordata | 1 | 2008 | 1 | 0.310 |
Why?
|
| Anticonvulsants | 3 | 2021 | 396 | 0.310 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 707 | 0.300 |
Why?
|
| Aminopyridines | 1 | 2009 | 60 | 0.300 |
Why?
|
| Animals | 21 | 2025 | 36217 | 0.280 |
Why?
|
| Pyramidal Cells | 2 | 2025 | 172 | 0.280 |
Why?
|
| Carbamates | 2 | 2025 | 68 | 0.270 |
Why?
|
| Autistic Disorder | 2 | 2022 | 376 | 0.270 |
Why?
|
| Status Epilepticus | 1 | 2009 | 154 | 0.270 |
Why?
|
| Amitriptyline | 2 | 2023 | 26 | 0.260 |
Why?
|
| Amino Acid Sequence | 5 | 2019 | 2785 | 0.260 |
Why?
|
| Mutation | 7 | 2023 | 6343 | 0.250 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2022 | 62 | 0.250 |
Why?
|
| Potassium Channels | 2 | 2004 | 166 | 0.240 |
Why?
|
| 4-Aminopyridine | 2 | 2023 | 35 | 0.230 |
Why?
|
| Sequence Alignment | 3 | 2015 | 631 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 3 | 2025 | 1152 | 0.230 |
Why?
|
| Developmental Disabilities | 2 | 2019 | 747 | 0.220 |
Why?
|
| Dogs | 2 | 2022 | 672 | 0.210 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 246 | 0.200 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 42 | 0.200 |
Why?
|
| Psyllium | 1 | 2022 | 13 | 0.200 |
Why?
|
| Cryptosporidium | 1 | 2022 | 33 | 0.190 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 41 | 0.190 |
Why?
|
| Parvalbumins | 1 | 2022 | 36 | 0.190 |
Why?
|
| Rats | 9 | 2016 | 3851 | 0.190 |
Why?
|
| Receptors, Nicotinic | 1 | 2022 | 139 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 787 | 0.180 |
Why?
|
| Ion Channel Gating | 1 | 2022 | 125 | 0.180 |
Why?
|
| Protein Binding | 3 | 2015 | 1852 | 0.180 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3960 | 0.180 |
Why?
|
| Language Development Disorders | 1 | 2022 | 179 | 0.170 |
Why?
|
| Humans | 22 | 2025 | 133331 | 0.170 |
Why?
|
| Colitis | 1 | 2022 | 164 | 0.170 |
Why?
|
| Epilepsies, Partial | 1 | 2021 | 95 | 0.170 |
Why?
|
| Abdomen | 1 | 2021 | 136 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 182 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 150 | 0.150 |
Why?
|
| Mice | 9 | 2025 | 18936 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4760 | 0.140 |
Why?
|
| Electroencephalography | 4 | 2021 | 896 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2015 | 1707 | 0.130 |
Why?
|
| Myoclonus | 1 | 2017 | 33 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2019 | 1597 | 0.120 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2015 | 8 | 0.120 |
Why?
|
| Synaptic Potentials | 1 | 2015 | 14 | 0.120 |
Why?
|
| Male | 10 | 2025 | 65576 | 0.120 |
Why?
|
| Cholinergic Fibers | 1 | 2015 | 9 | 0.120 |
Why?
|
| Neurons, Afferent | 1 | 2015 | 48 | 0.110 |
Why?
|
| Neural Crest | 1 | 2015 | 56 | 0.110 |
Why?
|
| Cricetulus | 3 | 2023 | 97 | 0.110 |
Why?
|
| Acetylcholine | 1 | 2015 | 86 | 0.110 |
Why?
|
| CHO Cells | 3 | 2023 | 167 | 0.110 |
Why?
|
| Superior Cervical Ganglion | 1 | 2014 | 15 | 0.110 |
Why?
|
| Oligodendroglia | 1 | 2014 | 79 | 0.110 |
Why?
|
| Spectrin | 1 | 2014 | 62 | 0.110 |
Why?
|
| Protein Phosphatase 1 | 1 | 2014 | 55 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1096 | 0.100 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8630 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2019 | 1147 | 0.100 |
Why?
|
| Indoles | 2 | 2006 | 202 | 0.100 |
Why?
|
| Calmodulin | 1 | 2014 | 223 | 0.100 |
Why?
|
| Perioperative Period | 1 | 2013 | 54 | 0.100 |
Why?
|
| Neuroglia | 1 | 2014 | 214 | 0.100 |
Why?
|
| Oocytes | 2 | 2022 | 302 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 965 | 0.090 |
Why?
|
| Phenotype | 4 | 2023 | 4577 | 0.080 |
Why?
|
| Hippocampus | 3 | 2016 | 861 | 0.080 |
Why?
|
| Transfection | 2 | 2016 | 1095 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2016 | 3131 | 0.080 |
Why?
|
| Flurothyl | 1 | 2009 | 2 | 0.080 |
Why?
|
| Female | 6 | 2025 | 71482 | 0.080 |
Why?
|
| Cricetinae | 2 | 2023 | 395 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2015 | 467 | 0.080 |
Why?
|
| Diazepam | 1 | 2009 | 21 | 0.080 |
Why?
|
| Kainic Acid | 1 | 2009 | 24 | 0.080 |
Why?
|
| Invertebrates | 1 | 2008 | 5 | 0.080 |
Why?
|
| Phenobarbital | 1 | 2009 | 35 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 69 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 212 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3363 | 0.070 |
Why?
|
| Cochlea | 1 | 2008 | 90 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2008 | 1731 | 0.070 |
Why?
|
| Survival Rate | 1 | 2013 | 2207 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2855 | 0.070 |
Why?
|
| Time Factors | 2 | 2009 | 6544 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2014 | 3979 | 0.070 |
Why?
|
| Phylogeny | 1 | 2008 | 781 | 0.060 |
Why?
|
| Phosphothreonine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 71 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2008 | 378 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2022 | 946 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2006 | 78 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2005 | 129 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1041 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1303 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2005 | 281 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1714 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2005 | 300 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2022 | 483 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 1079 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 670 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 402 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2006 | 254 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 259 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 389 | 0.060 |
Why?
|
| Arginine | 2 | 2017 | 350 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 367 | 0.050 |
Why?
|
| Myokymia | 1 | 2004 | 9 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 4823 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 1136 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17568 | 0.050 |
Why?
|
| Infant | 4 | 2019 | 13241 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 150 | 0.050 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 415 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 863 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 6582 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 14872 | 0.050 |
Why?
|
| Metronidazole | 1 | 2022 | 149 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7139 | 0.050 |
Why?
|
| Dysbiosis | 1 | 2022 | 145 | 0.040 |
Why?
|
| Interneurons | 1 | 2022 | 147 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 369 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 109 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 256 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2014 | 398 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 162 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 607 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 873 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2017 | 33 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2651 | 0.030 |
Why?
|
| Histidine | 1 | 2017 | 75 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3869 | 0.030 |
Why?
|
| Cysteine | 1 | 2017 | 143 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2019 | 376 | 0.030 |
Why?
|
| Pregnancy | 1 | 2009 | 7599 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 316 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1730 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 860 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 2015 | 11 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 217 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 2015 | 12 | 0.030 |
Why?
|
| Calcium Channels, T-Type | 1 | 2015 | 13 | 0.030 |
Why?
|
| Neurites | 1 | 2015 | 46 | 0.030 |
Why?
|
| Enteric Nervous System | 1 | 2015 | 43 | 0.030 |
Why?
|
| Aged | 1 | 2013 | 21497 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2015 | 55 | 0.030 |
Why?
|
| Marine Toxins | 1 | 2014 | 7 | 0.030 |
Why?
|
| Oxazoles | 1 | 2014 | 23 | 0.030 |
Why?
|
| Potassium | 1 | 2015 | 278 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 334 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 160 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 84 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2015 | 223 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 714 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 365 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1513 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 288 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 910 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 906 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 606 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1581 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1099 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3415 | 0.020 |
Why?
|
| Spiral Ganglion | 1 | 2008 | 10 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2524 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2008 | 169 | 0.020 |
Why?
|
| Hearing | 1 | 2008 | 62 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2008 | 233 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2008 | 198 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 174 | 0.020 |
Why?
|
| Child | 2 | 2019 | 25863 | 0.020 |
Why?
|
| Mammals | 1 | 2008 | 282 | 0.020 |
Why?
|
| Dendrites | 1 | 2008 | 204 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2008 | 708 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9920 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 156 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 63 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 1608 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 316 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1531 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1072 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2004 | 119 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2004 | 275 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 839 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31674 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 3223 | 0.010 |
Why?
|